1. Home
  2. QNCX vs PDSB Comparison

QNCX vs PDSB Comparison

Compare QNCX & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • PDSB
  • Stock Information
  • Founded
  • QNCX 2012
  • PDSB 2005
  • Country
  • QNCX United States
  • PDSB United States
  • Employees
  • QNCX N/A
  • PDSB N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • PDSB Biotechnology: Pharmaceutical Preparations
  • Sector
  • QNCX Health Care
  • PDSB Health Care
  • Exchange
  • QNCX Nasdaq
  • PDSB Nasdaq
  • Market Cap
  • QNCX 92.3M
  • PDSB 58.7M
  • IPO Year
  • QNCX 2019
  • PDSB N/A
  • Fundamental
  • Price
  • QNCX $1.60
  • PDSB $1.45
  • Analyst Decision
  • QNCX Strong Buy
  • PDSB Strong Buy
  • Analyst Count
  • QNCX 4
  • PDSB 3
  • Target Price
  • QNCX $9.50
  • PDSB $14.00
  • AVG Volume (30 Days)
  • QNCX 147.1K
  • PDSB 253.8K
  • Earning Date
  • QNCX 11-13-2024
  • PDSB 11-14-2024
  • Dividend Yield
  • QNCX N/A
  • PDSB N/A
  • EPS Growth
  • QNCX N/A
  • PDSB N/A
  • EPS
  • QNCX N/A
  • PDSB N/A
  • Revenue
  • QNCX N/A
  • PDSB N/A
  • Revenue This Year
  • QNCX N/A
  • PDSB N/A
  • Revenue Next Year
  • QNCX N/A
  • PDSB N/A
  • P/E Ratio
  • QNCX N/A
  • PDSB N/A
  • Revenue Growth
  • QNCX N/A
  • PDSB N/A
  • 52 Week Low
  • QNCX $0.51
  • PDSB $1.30
  • 52 Week High
  • QNCX $2.45
  • PDSB $6.68
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 42.75
  • PDSB 39.51
  • Support Level
  • QNCX $1.40
  • PDSB $1.37
  • Resistance Level
  • QNCX $1.79
  • PDSB $1.73
  • Average True Range (ATR)
  • QNCX 0.15
  • PDSB 0.14
  • MACD
  • QNCX -0.02
  • PDSB 0.03
  • Stochastic Oscillator
  • QNCX 32.79
  • PDSB 28.03

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: